Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Social Science & Medicine (1982)|June 14, 2022
Market access for medicines treating rare diseases: Association between specialised processes for orphan medicines and funding recommendationsAnna-Maria Fontrier
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 8, 2023
Do Reimbursement Recommendations by the Canadian Agency for Drugs and Technology in Health Translate Into Coverage Decisions for Orphan Drugs in the Canadian Province of Ontario?Anna-Maria Fontrier, Panos Kanavos
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 11, 2019
International impact of external reference pricing: should national policy-makers care?Anna-Maria Fontrier, Jennifer Gill, Panos Kanavos
Pharmacoeconomics - Open|November 30, 2021
Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 CountriesAnna-Maria Fontrier, Erica Visintin, Panos Kanavos
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 2, 2023
How can health technology assessment be improved to optimise access to medicines? Results from a Delphi study in Europe : Better access to medicines through HTAAnna-Maria Fontrier, Bregtje Kamphuis, Panos Kanavos
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 5, 2019
Does external reference pricing deliver what it promises? Evidence on its impact at national levelPanos Kanavos, Anna-Maria Fontrier, Jennifer Gill, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 25, 2019
Variations in external reference pricing implementation: does it matter for public policy?Jennifer Gill, Anna-Maria Fontrier, Dionysis Kyriopoulos, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|May 18, 2023
The patient pathway in ATTR-CM in Greece and how to improve it: A multidisciplinary perspectiveEfstratios A Apostolou, Anna-Maria Fontrier, Georgios K Efthimiadis, et al.
Health Policy (Amsterdam, Netherlands)|September 23, 2020
Pricing of in-patent pharmaceuticals in the Middle East and North Africa: Is external reference pricing implemented optimally?Panos Kanavos, Bregtje W Kamphuis, Anna-Maria Fontrier, et al.
Pageof 1